4The TIMI ⅢB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI ⅢB trial [J]. Circulation, 1994, 89:1545-1556.
5Barnett PG, Chen S, et al. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarelion: resuhs of a randomized trial [J]. Circulation, 2002, 105:680-684.
6Janzon M, Levin LA, et al. Cost effectiveness of an invasive strategy in unstable coronary artery disease;results from the FRISC Ⅱ invasive trial [J]. Eur Heart J, 2002, 23: 31-40.
7Mahoney EM, Jurkovitz CT,18 Investigators. Cost and costet al. TACTICS-TIMI effectiveness of an earlyinvasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction [J]. JAMA, 2002, 288: 1851-1858.
8Cohen DJ. Invasive vs conservative management of acute coronary syndromes [J]. JAMA, 2002, 288: 1905-1907.
9Kim J, Henderson RA, et al. Heahh-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results .of RITA-3 [J].J Am Coll Cardiol, 2005, 45:221-228.
10Boden WE. "Routine invasive" versus "selective invasire" approaches to non-ST-segrnent elevation acute coronary syndromes management in the post-stent/platelet inhibition era [J]. J Am Coll Cardiol, 2003, 19;41 (4 Suppl S): 113S-122S.
